{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:38Z","timestamp":1707525158605},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,2]]},"DOI":"10.7759\/cureus.39874","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T14:08:56Z","timestamp":1685714936000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom"],"prefix":"10.7759","author":[{"given":"Saroona","family":"Haroon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iresha","family":"Vithanage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khushbakht","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnoor","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Elmahdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamail","family":"Zia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umair Arshad","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atif A","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22539-5_4","article-title":"Melanoma: clinical presentations","volume":"167","author":"Kibbi N","year":"2016","unstructured":"Kibbi N, Kluger H, Choi JN. Melanoma: clinical presentations. Cancer Treat Res. 2016, 167:107-29. 10.1007\/978-3-319-22539-5_4","journal-title":"Cancer Treat Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6001\/actamedica.v24i1.3460","article-title":"Analysis of prognostic factors for melanoma patients","volume":"24","author":"Lideikait\u0117 A","year":"2017","unstructured":"Lideikait\u0117 A, Moz\u016braitien\u0117 J, Letautien\u0117 S. Analysis of prognostic factors for melanoma patients. Acta Med Litu. 2017, 24:25-34. 10.6001\/actamedica.v24i1.3460","journal-title":"Acta Med Litu"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib L","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 2021, 4:e214708. 10.1001\/jamanetworkopen.2021.4708","journal-title":"JAMA Netw Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32802","article-title":"Annual report to the nation on the status of cancer, part I: national cancer statistics","volume":"126","author":"Henley SJ","year":"2020","unstructured":"Henley SJ, Ward EM, Scott S, et al.. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer. 2020, 126:2225-49. 10.1002\/cncr.32802","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold M","year":"2022","unstructured":"Arnold M, Singh D, Laversanne M, et al.. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022, 158:495-503. 10.1001\/jamadermatol.2022.0160","journal-title":"JAMA Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4065\/72.3.267","article-title":"Malignant melanoma: basic approach to clinicopathologic correlation","volume":"72","author":"Su WP","year":"1997","unstructured":"Su WP. Malignant melanoma: basic approach to clinicopathologic correlation. Mayo Clin Proc. 1997, 72:267-72. 10.4065\/72.3.267","journal-title":"Mayo Clin Proc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-0327","article-title":"Time to get serious about skin cancer prevention","volume":"21","author":"Lazovich D","year":"2012","unstructured":"Lazovich D, Choi K, Vogel RI. Time to get serious about skin cancer prevention. Cancer Epidemiol Biomarkers Prev. 2012, 21:1893-901. 10.1158\/1055-9965.EPI-12-0327","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126395","article-title":"Aetiology and pathogenesis of cutaneous melanoma: current concepts and advances","volume":"22","author":"Strashilov S","year":"2021","unstructured":"Strashilov S, Yordanov A. Aetiology and pathogenesis of cutaneous melanoma: current concepts and advances. Int J Mol Sci. 2021, 22:6395. 10.3390\/ijms22126395","journal-title":"Int J Mol Sci"},{"key":"ref10","article-title":"Prognostic factors in patients with localized primary cutaneous melanoma","volume":"21","author":"Mervic L","year":"2012","unstructured":"Mervic L. Prognostic factors in patients with localized primary cutaneous melanoma. Acta Dermatovenerol Alp Pannonica Adriat. 2012, 21:27-31.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/ijc.IJC_612_17","article-title":"Clinicopathological study of malignant melanoma in a regional cancer center","volume":"55","author":"Panda S","year":"2018","unstructured":"Panda S, Dash S, Besra K, Samantaray S, Pathy PC, Rout N. Clinicopathological study of malignant melanoma in a regional cancer center. Indian J Cancer. 2018, 55:292-6. 10.4103\/ijc.IJC_612_17","journal-title":"Indian J Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01644.x","article-title":"Clinicopathological features and prognostic factors of cutaneous melanoma among Hong Kong Chinese","volume":"29","author":"Luk NM","year":"2004","unstructured":"Luk NM, Ho LC, Choi CL, Wong KH, Yu KH, Yeung WK. Clinicopathological features and prognostic factors of cutaneous melanoma among Hong Kong Chinese. Clin Exp Dermatol. 2004, 29:600-4. 10.1111\/j.1365-2230.2004.01644.x","journal-title":"Clin Exp Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.180822","article-title":"A clinicopathologic study of malignant melanoma based on cytomorphology","volume":"53","author":"Radhika K","year":"2016","unstructured":"Radhika K, Prayaga AK, Sundaram C. A clinicopathologic study of malignant melanoma based on cytomorphology. Indian J Cancer. 2016, 53:199-203. 10.4103\/0019-509X.180822","journal-title":"Indian J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000519193","article-title":"The incidence of cutaneous malignant melanoma in Eastern Newfoundland and Labrador, Canada, from 2007 to 2015","volume":"238","author":"Gulliver W","year":"2022","unstructured":"Gulliver W, Gulliver S, Power RJ, Penney M, Lane D. The incidence of cutaneous malignant melanoma in Eastern Newfoundland and Labrador, Canada, from 2007 to 2015. Dermatology. 2022, 238:527-33. 10.1159\/000519193","journal-title":"Dermatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13866","article-title":"An update on cutaneous melanoma in Turkey: evaluation of 19-year data in a single tertiary centre and review of the literature","volume":"31","author":"Baykal C","year":"2017","unstructured":"Baykal C, Atci T, Polat Ekinci A, Buyukbabani N. An update on cutaneous melanoma in Turkey: evaluation of 19-year data in a single tertiary centre and review of the literature. J Eur Acad Dermatol Venereol. 2017, 31:236-40. 10.1111\/jdv.13866","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2019.34.e126","article-title":"Clinicopathologic features and prognostic factors of primary cutaneous melanoma: a multicenter study in Korea","volume":"34","author":"Kim JE","year":"2019","unstructured":"Kim JE, Chung BY, Sim CY, et al.. Clinicopathologic features and prognostic factors of primary cutaneous melanoma: a multicenter study in Korea. J Korean Med Sci. 2019, 34:e126. 10.3346\/jkms.2019.34.e126","journal-title":"J Korean Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200412000-00016","article-title":"Malignant melanoma in Taiwan: a prognostic study of 181 cases","volume":"14","author":"Chang JW","year":"2004","unstructured":"Chang JW, Yeh KY, Wang CH, et al.. Malignant melanoma in Taiwan: a prognostic study of 181 cases. Melanoma Res. 2004, 14:537-41. 10.1097\/00008390-200412000-00016","journal-title":"Melanoma Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaa097","article-title":"Subtyping cutaneous melanoma matters","volume":"4","author":"El Sharouni MA","year":"2020","unstructured":"El Sharouni MA, van Diest PJ, Witkamp AJ, Sigurdsson V, van Gils CH. Subtyping cutaneous melanoma matters. JNCI Cancer Spectr. 2020, 4:pkaa097. 10.1093\/jncics\/pkaa097","journal-title":"JNCI Cancer Spectr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000253","article-title":"Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas","volume":"26","author":"Lin RL","year":"2016","unstructured":"Lin RL, Wang TJ, Joyce CJ, Mihm MC Jr, Murphy GF, Lian CG, Lin JY. Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas. Melanoma Res. 2016, 26:524-7. 10.1097\/CMR.0000000000000253","journal-title":"Melanoma Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000002264","article-title":"Major histotypes in skin melanoma: nodular and acral lentiginous melanomas are poor prognostic factors for relapse and survival","volume":"44","author":"Tas F","year":"2022","unstructured":"Tas F, Erturk K. Major histotypes in skin melanoma: nodular and acral lentiginous melanomas are poor prognostic factors for relapse and survival. Am J Dermatopathol. 2022, 44:799-805. 10.1097\/DAD.0000000000002264","journal-title":"Am J Dermatopathol"},{"key":"ref21","article-title":"Patients' characteristics, histopathological findings, and tumor stage in different types of malignant melanoma: a retrospective multicenter study","volume":"55","author":"Farahmand AM","year":"2017","unstructured":"Farahmand AM, Ehsani AH, Mirzaei M, Mohsenian M, Ghanadan A. Patients' characteristics, histopathological findings, and tumor stage in different types of malignant melanoma: a retrospective multicenter study. Acta Med Iran. 2017, 55:316-23.","journal-title":"Acta Med Iran"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20132036","article-title":"Epidemiological and histopathological profile of cutaneous melanoma at a center in northeastern Brazil from 2000 to 2010","volume":"88","author":"Vilanova CM","year":"2013","unstructured":"Vilanova CM, Lages RB, Ribeiro SM, Almeida IP, Santos LG, Vieira SC. Epidemiological and histopathological profile of cutaneous melanoma at a center in northeastern Brazil from 2000 to 2010. An Bras Dermatol. 2013, 88:545-53. 10.1590\/abd1806-4841.20132036","journal-title":"An Bras Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88391-5","article-title":"High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens","volume":"11","author":"Cheng LY","year":"2021","unstructured":"Cheng LY, Haydu LE, Song P, et al.. High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens. Sci Rep. 2021, 11:9043. 10.1038\/s41598-021-88391-5","journal-title":"Sci Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/path.5213","article-title":"Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities","volume":"247","author":"Rabbie R","year":"2019","unstructured":"Rabbie R, Ferguson P, Molina-Aguilar C, Adams DJ, Robles-Espinoza CD. Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities. J Pathol. 2019, 247:539-51. 10.1002\/path.5213","journal-title":"J Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/162024-clinicopathological-profile-of-a-cohort-of-patients-with-malignant-melanoma-in-the-united-kingdom","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:41Z","timestamp":1707509081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/162024-clinicopathological-profile-of-a-cohort-of-patients-with-malignant-melanoma-in-the-united-kingdom"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.39874","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,2]]}}}